Monitoring of Foreign Drug Safety Information

Monitoring of Foreign Drug Safety Information

Analysis of administrative decisions of foreign regulatory authorities on the recoil of medicines and/or the need for changes in the instructions for their medical use due to changes in the safety profile, conducted by experts of the Scientific Centre for Expert Evaluation of Medicinal Products reve...

Full description

Bibliographic Details
Main Author:	Editorial article
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2019-12-01
Series:	Безопасность и риск фармакотерапии
Subjects:	adverse reactions postmarketing studies security profile drugs instructions for medical use pharmacovigilance
Online Access:	https://www.risksafety.ru/jour/article/view/164

Similar Items

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

Monitoring Drug Safety Information - Recommendations of Foreign Regulatory Authorities
by: Elena V. Shubnikova, et al.
Published: (2020-03-01)

Analysis of the decisions of foreign regulatory authorities
by: Relevant information
Published: (2019-06-01)

Analysis of Administrative Decisions of Foreign Regulatory Authorities
by: Information relevant
Published: (2019-09-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01)

Drug Safety Monitoring Information
by: Elena V. Shubnikova, et al.
Published: (2020-06-01)

From Monitoring Drug Safety to Monitoring Patient Safety: A Strategic Focus for the Activity of Pharmacists
by: Francisco Batel Marques
Published: (2017-10-01)

POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS
by: E. V. Shubnikova, et al.
Published: (2018-09-01)

Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital
by: Fabiana Rossi Varallo, et al.
Published: (2014-03-01)

Comparison of rates of nausea side effects for prescription medications from an online patient community versus medication labels: an exploratory analysis
by: David A. Blaser, et al.
Published: (2017-11-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)

Development of instrument to report and assess causality of adverse events related to herbal medicines
by: Patrícia de Carvalho Mastroianni, et al.

Development of instrument to report and asses causality of adverse events related to herbal medicines
by: Patricia de Carvalho MASTROIANNI, et al.
Published: (2017-04-01)

Drug therapeutic failures as a cause of admission to an intensive care unit at a university hospital
by: Jair Antonio Ruiz-Garzon, et al.
Published: (2019-01-01)

Characteristics of Phase IV Clinical Trials in Oncology: An Analysis Using the ClinicalTrials.gov Registry Data
by: Brandon Michael Henry, et al.
Published: (2023-06-01)

Current Information on the Safety of Medicinal Products: Decisions of Foreign Regulatory Authorities
by: E. V. Shubnikova
Published: (2024-04-01)

Knowledge, attitude, practices, and barriers regarding pharmacovigilance and adverse drug reaction reporting among medical and dental faculties of the teaching hospitals in Bhubaneswar City
by: Avinash Jnaneswar, et al.
Published: (2020-01-01)

Safety Profile of Biological Drugs in Clinical Practice: A Retrospective Pharmacovigilance Study
by: Elaaf Fadhil Hassan, et al.
Published: (2022-06-01)

DRUG SAFETY MONITORING SERVICE IN DEVELOPING ORGANIZATIONS / MANUFACTURERS OF DRUGS FOR VETERINARY USE
by: N. P. Biryukova, et al.
Published: (2019-09-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

Comparing epidemiological methods in detecting drug safety signal in IRAN
by: G Shalviri, et al.
Published: (2005-12-01)

Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
by: Pramod Kumar, et al.
Published: (2017-01-01)

Assessment of incidence, causality, severity, and preventability of suspected adverse drug reactions to antidepressant medications in a psychiatry outpatient setting of a secondary care hospital
by: Moza Salem Rashed Al Zaabi, et al.
Published: (2020-01-01)

Role of hospital pharmacists in reporting adverse drug reactions – A review
by: Sharmila P Nirojini, et al.
Published: (2012-01-01)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
by: Kishor A Bansod, et al.
Published: (2020-01-01)

Adverse drug reactions among patients admitted with infectious diseases at a Brazilian hospital
by: Pamela Alejandra Saavedra, et al.

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance
by: K. S. Milchakov
Published: (2022-10-01)

An evaluation of trigger tool method for adverse drug reaction monitoring at a tertiary care teaching hospital
by: Urmila Menat, et al.
Published: (2021-01-01)

Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
by: Acquavella J, et al.
Published: (2016-07-01)

Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies
by: Valerio Ciccone, et al.
Published: (2023-06-01)

Adverse reactions by antibiotics and non-steroidal anti-inflammatory drugs
by: Karen Orellana, et al.
Published: (2022-03-01)

Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China
by: Xiaofang Tan, et al.
Published: (2020-10-01)

Reporting of adverse drug reactions due to cardiovascular drugs in India: A national duty
by: Vivekanandan Kalaiselvan
Published: (2015-11-01)

Materiovigilance: An Indian perspective
by: Bikash Ranjan Meher
Published: (2018-01-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

A Semantic Transformation Methodology for the Secondary Use of Observational Healthcare Data in Postmarketing Safety Studies
by: Anil Pacaci, et al.
Published: (2018-04-01)

Pharmacovigilance: Scope for a dermatologist
by: Bhanu Prakash, et al.
Published: (2011-01-01)

A 5 year retrospective analysis of pharmacovigilance study, completeness and quality of suspected adverse drug reaction forms at adverse drug reaction monitoring center Port Blair.
by: Priyanka Hotha, et al.
Published: (2021-12-01)